The next generation of positron emission tomography (PET) imaging agents will herald an age when PET will eclipse single ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of bomb ...
March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 26, 2013 โ The Society of Nuclear Medicine and Molecular Imaging (SNMMI) released a list of specific tests that ...
February 13, 2013 โ Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ...
February 8, 2013 โ While amyloid imaging may now be most associated with detecting plaques in the brain, it has the ...
The introduction of hybrid technology โ positron emission tomography/computed tomography (PET/CT) and single-photon ...
The Philips Healthcare Ambient Experience integrates architecture, design and enabling technologies, such as dynamic ...
October 25, 2012 โ Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply ...
October 5, 2012 โ Imagine a place where doctors can tell patients in advance if cancer treatment will work for them ...
September 12, 2012ย โ Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and ...
August 27, 2012 โ Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...
August 21, 2012 โ The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...
August 20, 2012 โ Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...
August 14, 2012ย โ Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical operat ...
May 14, 2013